Detalhe da pesquisa
1.
Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer.
Int J Pharm
; 587: 119655, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712252
2.
Comparison of 2 strategies to enhance pyridoclax solubility: Nanoemulsion delivery system versus salt synthesis.
Eur J Pharm Sci
; 97: 218-226, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916693
3.
Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent.
Int J Pharm
; 320(1-2): 157-64, 2006 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-16723200
4.
Evaluation of the versatile character of a nanoemulsion formulation.
Int J Pharm
; 498(1-2): 49-65, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26685727
5.
Interactions between hen egg-white lysozyme, PEG2,000, and PLA50 at the air-water interface.
Colloids Surf B Biointerfaces
; 42(2): 97-106, 2005 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15833660
6.
Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
Int J Pharm
; 458(1): 197-207, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24084450
7.
Partial least squares analysis and mixture design for the study of the influence of composition variables on lipidic nanoparticle characteristics.
J Pharm Sci
; 99(11): 4603-15, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20845459
8.
Influence of the introduction of a solubility enhancer on the formulation of lipidic nanoparticles with improved drug loading rates.
Eur J Pharm Biopharm
; 75(2): 117-27, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20144710